← Back to Search

Procedure

ACLR with lateral extra-articular tenodesis for Ruptured Achilles Tendon

N/A
Waitlist Available
Led By Laith Jazrawi, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing whether adding a surgery to fix a torn ACL improves the healing process, by comparing MRI results of those who had the extra surgery to those who did not.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine if ACLR supplementation with LET results in superior MRI findings relative to ACLR alone
Secondary outcome measures
Graft Failure

Trial Design

2Treatment groups
Experimental Treatment
Group I: ACLR with lateral extra-articular tenodesisExperimental Treatment1 Intervention
All LETs will be performed in a standardized fashion using the modified Lameire technique.
Group II: ACLRExperimental Treatment1 Intervention
All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,635 Total Patients Enrolled
Laith Jazrawi, MDPrincipal InvestigatorNew York Langone Health
3 Previous Clinical Trials
285 Total Patients Enrolled
Michael Alaia, MDPrincipal InvestigatorNew York Langone Health
3 Previous Clinical Trials
268 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025